Co-administering a drug for treating HIV called dolutegravir with two common TB medicines can safely shorten TB treatment, a study says.
The WHO estimates that those living with HIV are 20 to 30 times more likely to develop active TB, with a third of all HIV deaths every year being attributed to TB. Read More
